Trial · NCT04684719
Registered outcomes21
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 21
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | 30-day mortality | Enrollment through 30 days | All cause mortality within 30 days |
| Secondary | Age of whole blood | During Procedure | Age of units of whole blood in days categorized into young (1-14 days) and old (\>14 days) and compared across primary and secondary outcomes |
| Secondary | 3-hour mortality | Enrollment through 3 hours | Death within 3 hours of enrollment |
| Secondary | 6-hour mortality | Enrollment through 6 hours | Death within 6 hours of enrollment |
| Secondary | 24-hour mortality | Enrollment through 24 hours | Death within 24 hours of enrollment |
| Secondary | In-hospital mortality | Enrollment through hospital discharge or 30 days | Death prior to hospital discharge |
| Secondary | Time to death | Enrollment through death or 30 days | Time in days from enrollment to death |
| Secondary | Blood and blood component transfusion type | Enrollment through 24 hours | Type of blood or blood component required for transfusion |
| Secondary | Blood and blood component transfusion amount | Enrollment through 24 hours | Number of units of blood or blood component transfused |
| Secondary | Time to blood and blood component transfusion | Enrollment time to first transfusion | Amount of time from enrollment to transfusion of blood or blood component |
| Secondary | Multiple Organ Failure (MOF) | Enrollment through 7 days or ICU discharge | Organ dysfunction will be evaluated via the Denver Post-injury Multiple Organ Failure Score. Patients who are never admitted to the Intensive Care Unit (ICU) or those with a length of ICU stay of less than 48 hours will be considered to have a Denver score of 0. A summary of the Denver score may be calculated by summing the worst scores of each of the individual systems over the course of the ICU stay. A summary Denver score \> 3 will be classified as MOF. |
| Secondary | Hospital-acquired pneumonia | Number of participants who develop pneumonia through 30 days | Pneumonia acquired during hospitalization per Center for Disease Control (CDC) criteria |
| Secondary | blood stream infection | Number of participants who develop blood stream infection through 30 days | Blood stream infection during hospitalization per CDC criteria |
| Secondary | Acute Respiratory Distress Syndrome (ARDS) | Number of participants who develop ARDS through 30 days | The Berlin definition for mild ARDS (PaO2/FIO2, ≤ 300 mm Hg + timing, imaging and origin criteria) will be utilized as a threshold value to determine the incidence of ARDS and will be further stratified into Moderate (PaO2/FIO2, ≤ 200 mm Hg) and Severe (PaO2/FIO2, ≤ 100 mm Hg). |
| Secondary | Prothrombin Time (PT) | Enrollment through 60 minutes and 24 hours | Measurement of platelet hemostatic function |
| Secondary | International Normalized Ratio (INR) | Enrollment through 60 minutes and 24 hours | Measurement of platelet hemostatic function |
| Secondary | Incidence of coagulopathy by rapid thrombelastography (rTEG) | Enrollment through 60 minutes and 24 hours | Coagulopathy as indicated by rTEG measures |
| Secondary | rTEG platelet function | Enrollment through 60 minutes and 24 hours | rTEG measurement of platelet hemostatic function |
| Secondary | Time to hemostasis | Enrollment through 4 hours | Ability to reach nadir transfusion requirement of 1 unit of red blood cells in a 60-minute time period in the first 4 hours following arrival |
| Secondary | Transfusion reaction | Enrollment through 24 hours | Any transfusion complication |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04684719/registered